Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady

Better Medicare quality scores are reordering the managed care rankings, and shares of Humana (NYSE:HUM | HUM Price Prediction) are setting the pace. Humana stock is at $447, up 15% early in the session, after the insurer disclosed improved Star Ratings for its 2027 plan year. A ratings cycle that once weighed on the company is now working in its favor, and Humana stock is adjusting to match.

Meanwhile, shares of CVS Health (NYSE:CVS) are heading the opposite way at $85, down 3%. At the same time, UnitedHealth Group (NYSE:UNH) stock is holding steady at $372.24, up 0.4%, a far smoother reading than either rival.

For a sector read, the Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is unchanged. As a benchmark, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 0.33%. With the healthcare fund flat while the broad-market fund rises, the pattern points to a adjusting among insurers rather than a sector advance.

Higher Star Ratings Spark a Humana Rally

Humana stated that 95% of its Medicare Advantage members are enrolled in plans rated four stars or above by the Centers for Medicare and Medicaid Services (CMS). The company also reported improvement across all measure categories, plus eleven more Medicare Advantage contracts at the four-star level or higher than a year earlier. Chief executive Jim Rechtin said the ratings reflect the work of thousands of Humana employees helping members get high-quality care.

Behind the improvement, Humana pointed to engagement work aimed at members overdue for preventive care. That outreach produced more completed mammograms, colorectal screenings and diabetic eye exams, along with earlier detection of cancers and diabetes-related eye disease, according to the company. Those clinical gains feed directly into the quality measures CMS scores, which is why Humana’s operating work and its ratings outcome tend to move together.

Why One Ratings Release Splits Three Insurers

Humana offers Medicare Advantage and prescription drug plans alongside CenterWell, its healthcare services arm, so a ratings cycle touches a large share of what the company sells. CVS Health and UnitedHealth each carry insurance alongside sizable pharmacy and care-delivery operations, which is why one ratings release reaches the three differently. For Humana, quality scores sit near the core of the business; for the two diversified rivals, those ratings are one input among many.

A slide in CVS Health shares while Humana stock rallies stands out, since a ratings release is read against each insurer’s own book, and the gap between the two moves is wide, with Humana stock up by double digits and CVS Health shares in the red. Each insurer’s starting ratings mix, plan footprint and membership base shape how a release like this one lands.

What to Watch Next

The bull case for Humana rests on better ratings arriving as the annual election period opens, which is when plan selection is decided. Stronger scores can help Humana’s plans stand out to seniors comparing coverage during that window. Shareholders can see if that edge shows up in the company’s enrollment trends.

However, Star Ratings reset every year, so Humana’s improvement has to hold for the benefit to last. A double-digit jump on a single disclosure also pulls some of that hoped-for durability into Humana stock right away. Traders may want to keep an eye on whether CVS stock and UnitedHealth stock find their footing as the ratings news settles.

Contact [email protected] for any questions or corrections.